ANALISIS EFEKTIVITAS BIAYA PENGOBATAN DIABETES MELITUS TIPE 2 DALAM KEADAAN KHUSUS (GAGAL GINJAL KRONIS) RAWAT JALAN DI RSUD WELAS ASIH PROVINSI JAWA BARAT

LINA NUR AZIZAH, - (2025) ANALISIS EFEKTIVITAS BIAYA PENGOBATAN DIABETES MELITUS TIPE 2 DALAM KEADAAN KHUSUS (GAGAL GINJAL KRONIS) RAWAT JALAN DI RSUD WELAS ASIH PROVINSI JAWA BARAT. Skripsi thesis, Sekolah Tinggi Farmasi Indonesia.

	Text S_PSSF_A233008_Title.pdf Download (414kB)
	Text S_PSSF_A233008_Chapter1.pdf Restricted to Repository staff only Download (220kB)
	Text S_PSSF_A233008_Chapter2.pdf Restricted to Repository staff only Download (334kB)
	Text S_PSSF_A233008_Chapter3.pdf Restricted to Repository staff only Download (309kB)
	Text S_PSSF_A233008_Chapter4.pdf Restricted to Repository staff only Download (352kB)
	Text S_PSSF_A233008_Chapter5.pdf Restricted to Repository staff only Download (211kB)
	Text S_PSSF_A233008_Appendix.pdf Restricted to Repository staff only Download (965kB)

Abstract

Diabetes melitus tipe 2 merupakan penyebab nefropati yang paling banyak sebagai penyebab terjadinya gagal ginjal kronis. Tujuan dari penelitian ini diantaranya mengetahui biaya yang paling cost-effective pada pasien terdiagnosa diabetes melitus tipe 2 dengan komplikasi gagal ginjal kronis dan mengetahui regimen yang paling mempengaruhi efektivitas biaya pada pasien terdiagnosa diabetes melitus tipe 2 dengan komplikasi gagal ginjal kronis di RSUD Welas Asih Provinsi Jawa Barat. Metode penelitian ini dengan pendekatan purposive sampling dengan pengambilan data secara retrospektif berupa data rekam medis dan data keuangan pasien DM tipe 2 komplikasi gagal ginjal kronis rawat jalan di RSUD Welas Asih Provinsi Jawa Barat tahun 2024. Analisis data dilakukan menggunakan Average Cost-Effectiveness Ratio (ACER), Incremental Cost Effectiveness Ratio (ICER) dan analisis sensitivitas. Hasil analisis efektivitas terapi dan efektivitas biaya didapatkan hasil terapi pioglitazone lebih Cost-efektif dengan nilai efektivitas terapi (55,56%) dan nilai ACER Rp.57.753 dibandingkan dengan terapi insulin glulisin dengan efektivitas terapi (44,44%) dan nilai ACER Rp.136.281, sehingga didapatkan hasil ICER sebesar Rp.256.053. Hasil analisis sensitivitas menunjukkan bahwa terapi insulin glulisin lebih mempengaruhi efektivitas biaya karena memiliki rentang bar terpanjang. Kesimpulannya bahwa terapi pioglitazone lebih cost-effectiveness dibandingkan terapi insulin glulisin dan hasil analisis sensitivitas yang paling mempengaruhi terdapat pada terapi insulin glulisin. ----- Type 2 diabetes mellitus is the most common cause of nephropathy as a cause of chronic kidney disease. The objectives of this study include determining the most cost-effective costs in patients diagnosed with type 2 diabetes mellitus with complications of chronic kidney disease and determining the regimen that most influences cost-effectiveness in patients diagnosed with type 2 diabetes mellitus with complications of chronic kidney disease at Welas Asih Regional Hospital, West Java Province. This research method uses a purposive sampling approach with retrospective data collection in the form of medical records and financial data of outpatients with type 2 diabetes mellitus with complications of chronic kidney disease at Welas Asih Regional Hospital, West Java Province in 2024. Data analysis was performed using the Average Cost-Effectiveness Ratio (ACER), Incremental Cost-Effectiveness Ratio (ICER) and sensitivity analysis. The results of the analysis of therapeutic effectiveness and cost effectiveness showed that pioglitazone therapy was more cost-effective with a therapeutic effectiveness value (55.56%) and an ACER value of Rp. 57,753 compared to glulisin insulin therapy with a therapeutic effectiveness (44.44%) and an ACER value of Rp. 136,281, so that the ICER result was Rp.256,053. The results of the sensitivity analysis showed that glulisin insulin therapy had a greater effect on cost-effectiveness because it had the longest bar range. The conclusion is that pioglitazone therapy is more cost-effective than glulisin insulin therapy and the results of the sensitivity analysis that had the most influence were on glulisin insulin therapy.

Item Type:	Thesis (Skripsi)
Uncontrolled Keywords:	Diabetes Melitus Tipe 2, Gagal Ginjal Kronis, Analisis Efektivitas Biaya (ACER dan ICER), Insulin glulisin, Pioglitazone. ----- Type 2 Diabetes Mellitus, Chronic Kidney Disease, Cost Effectiveness Analysis (ACER and ICER), Glulisin Insulin, Pioglitazone
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions:	Program Studi S1 Farmasi
Depositing User:	pustakawan - -
Date Deposited:	28 Aug 2025 02:41
Last Modified:	28 Aug 2025 02:41
URI:	http://repository.stfi.ac.id/id/eprint/2707

Actions (login required)

View Item